Compare KraneShares Hang Seng TECH Index ETF (KTEC) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KraneShares Hang Seng TECH Index ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? KraneShares Hang Seng TECH Index ETF trades at $11.82 (market cap $45.04M), while Royalty Pharma plc Class A Ordinary Shares trades at $56.82 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 561.1× KraneShares Hang Seng TECH Index ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while KraneShares Hang Seng TECH Index ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold KraneShares Hang Seng TECH Index ETF for 44 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| KTEC | RPRX | |
|---|---|---|
Market Cap | $45.04M | $25.27B |
Volume | 29,043 | 3,671,183 |
Sector | Sector/Thematic | Health |
52-Week High | $18.73 | $63.96 |
52-Week Low | $11.41 | $35.44 |
Typical Hold Time | 44 Days | 1 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KraneShares Hang Seng TECH Index ETF
KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
